Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Cancer Biochemistry Biophysics|November 1, 1995
Antitumor effects of pirarubicin and epirubicin in combination with doxifluridine and cisplatin against mouse P388 leukemiaN Agata, T Mase, H Izumi, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|October 23, 1997
[A case of thymic cyst and thymoma with myasthenia gravis]H Yamamura, T Mase, K Shioi, et al.Chemical & Pharmaceutical Bulletin|March 22, 2000
A novel class of inhibitors for human steroid 5alpha-reductase: synthesis and biological evaluation of indole derivatives. IIS Igarashi, H Inami, H Hara, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 29, 2000
Bone metabolic analysis in patients with primary hyperparathyroidismY Tanaka, T Naruse, H Funahashi, et al.Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1990
Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factorT Yamada, K Tomioka, M Saito, et al.Lipids|December 1, 1991
Pharmacological properties of YM461, a new orally active platelet-activating factor antagonistT Yamada, M Saito, T Mase, et al.Journal of Medicinal Chemistry|April 11, 1997
N-[2-[(substituted chroman-8-yl)oxy]ethyl]-4-(4-methoxyphenyl)butylamines: synthesis and wide range of antagonism at the human 5-HT1A receptorT Yasunaga, R Naito, T Kontani, et al.Journal of Molecular Biology|March 26, 1998
Solution structure of calmodulin-W-7 complex: the basis of diversity in molecular recognitionM Osawa, M B Swindells, J Tanikawa, et al.The Journal of Pharmacy and Pharmacology|October 1, 1987
Isolated tissue and binding studies of YM-17690, a novel and non-analogous leukotriene agonistK Tomioka, T Yamada, K Teramura, et al.Neuroscience Research|August 1, 1997
Remyelination in the rat dorsal funiculus following demyelination by laser irradiationK Sato, E Ohmae, E Senoo, et al.Pageof 7